Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management; and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.Cardiovascular Revascularization Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and interesting images are encouraged.
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.
Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.
Cardiovascular Ultrasound is ready to receive manuscripts on all aspects of ultrasound in cardiovascular physiology and disease.
Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth, reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Career Development International provides a platform for research in the areas of Careers and Development that deals with questions of theories and theory development, as well as with organizational career strategy, policy and practice
Throughout the Caribbean there are groups of men and women who are coming together to learn – to deepen their intellectual interests, to find out through discussion and reading more about themselves, their history, the lands in which they live, the world round about them. This journal is published for these men and women . . . for all men and women who seek after knowledge; to be a bond between them, and to give them information about each other. Caribbean Quarterly (CQ) will aim at accuracy, objectivity, and clean thought, clearly expressed. Above all it seeks to establish and strengthen the tradition of the book and of learning in the Caribbean.
Philip Sherlock, co-editor, Caribbean Quarterly, 1.1 (April–June 1949)
Caribbean Quarterly (CQ) is one of the oldest periodicals in the English-speaking Caribbean. Regarded as the flagship publication of the University of the West Indies (UWI), it was launched by the then Department of Extra Mural Studies, UWI, in 1949, to be a platform from which research findings and general knowledge could be effectively disseminated within the campus and non-campus territories. Professor Rex Nettleford served as editor of CQ for forty years, until his death in February 2010. CQ is now produced under the umbrella of the Vice Chancellery.
CQ concerns itself with all aspects of Caribbean culture, in all its interdisciplinary ramifications. It is an outlet for the publication of results of research into, considered views on, and creative expressions of matters Caribbean. CQ publishes scholarly articles, personal and critical essays, public lectures, poetry, short fiction and book reviews – a lively diversity of types of writing reflecting the diversity of Caribbean culture. We invite original (previously unpublished) submissions on topics which are of general interest and relevance to the Caribbean. All scholarly articles are peer-reviewed: we insist on scholarly rigour, but we also encourage accessibility and discourage excessive use of academic jargon. Our aim is to produce high-quality material that can be understood by well-educated people from any discipline. Overall, we seek to paint a vivid picture of life in one of the most culturally diverse parts of the Western hemisphere, with information on its social and material culture, ethnology, history, peoples, religion and creative arts presented in a refreshingly accessible format.
Caries Research publishes epidemiological, clinical, and laboratory studies in dental caries, fluorosis, erosion, and related dental diseases. Some studies build on the considerable advances already made in caries prevention, e.g. through fluoride application. Some aim to improve understanding of the increasingly important problem of dental erosion and the associated tooth wear process. Others monitor the changing pattern of caries in different populations, explore improved methods of diagnosis, or evaluate methods of prevention or treatment. Studies using genetic methods to identify human genes or mutations associated with caries prevalence are welcome as are manuscripts using modern high-throughput sequencing methods to characterize microbial biofilms associated with oral health and active caries. The broad coverage of innovative research into dental caries is unique and has given the journal an outstanding international reputation as an indispensable source for both basic scientists and clinicians engaged in understanding, investigating, and preventing dental diseases.